Table 3. Haplotype frequencies of XRCC1, and odds ratios for pancreatic cancer associated with XRCC1 haplotype.
Haplotype | SNPsa | Haplotype frequency | Adjusted ORb
(cases/controls 185/1465) |
P-value | |||
|
|
||||||
1 (C>T) |
2 (G>A) |
Overall | Cases | Controls | |||
1 | C | G | 0.439 | 0.433 | 0.442 | 1.00 (ref.) | |
2 | C | A | 0.240 | 0.274 | 0.239 | 1.32 (1.01–1.71) | 0.042 |
3 | T | G | 0.319 | 0.292 | 0.318 | 1.05 (0.81–1.36) | 0.691 |
4 | T | A | 0.002 | <0.001 | 0.002 | N.E. | N.E. |
Abbreviation: OR, odds ratio.
aSNP 1 is rs1799782; SNP 2 is rs25487.
bHaplotype-effects logistic regression for case-control data was used. Multivariable adjustment by age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, and family history of PC.